Tech Company Financing Transactions
Pangea Biomed Funding Round
Private investors and NFX participated in a $5 million funding round for Pangea Biomed. The financing round was announced on 12/16/2022.
Transaction Overview
Company Name
Announced On
12/16/2022
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Undisclosed
Investors
private investors (Lead Investor) (Danny Tocatly)
NFX (Lead Investor)
Proceeds Purpose
The company intends to use the funds to expand US operations, drive commercial partnerships, and scale product offerings.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2A HaBarzel St.
Tel Aviv, Undisclosed
Israel
Tel Aviv, Undisclosed
Israel
Phone
Undisclosed
Website
Email Address
Overview
Pangea Biomed is an RNA-focused precision oncology biotech company on a mission to redefine cancer care. This will be achieved by significantly accelerating drug discovery and development, charting a highly personalized treatment course for each patient, and improving clinical efficiency and outcomes.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Tuvik Beker
Chairman
Eyal Schiff
Chief Operating Officer
Emmanuel Elalouf
Chief Technical Officer
Ranit Aharonov
Co-Founder
Ze'ev Ronai
Browse more venture capital transactions:
Prev: 12/16/2022: Infinity AI venture capital transaction
Next: 12/16/2022: Virgio venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs